Trial intelligence / Profile preview

Phase III trial of Congrongruntong Keli in adults with functional constipation

CTR20240944Phase 3Completed

Sponsor
Ruiyang Pharmaceutical
Start
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Congrongruntong Keli in functional constipation (FC), sponsored by Ruiyang Pharmaceutical. Started Mar 2024; status: completed.

02

Drugs

Congrongruntong Keli
03

Conditions

functional constipation (FC)

Beyond the preview

Go deeper on CTR20240944.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20240944.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call